These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24634829)

  • 1. Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.
    Kim JH; Meyers MS; Khuder SS; Abdallah SL; Muturi HT; Russo L; Tate CR; Hevener AL; Najjar SM; Leloup C; Mauvais-Jarvis F
    Mol Metab; 2014 Apr; 3(2):177-90. PubMed ID: 24634829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
    Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antagonist properties of Bazedoxifene after acute treatment are shifted to stimulatory action after chronic exposure in the liver but not in the uterus.
    Buscato M; Fontaine C; Fabre A; Vinel A; Valera MC; Noirrit E; Guillaume M; Payrastre B; Métivier R; Arnal JF
    Mol Cell Endocrinol; 2018 Sep; 472():87-96. PubMed ID: 29183806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.
    Song Y; Santen RJ; Wang JP; Yue W
    Endocrinology; 2012 Dec; 153(12):5706-15. PubMed ID: 23070546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS; Mirkin S; Jenkins SN
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex.
    Andersson A; Bernardi AI; Nurkkala-Karlsson M; Stubelius A; Grahnemo L; Ohlsson C; Carlsten H; Islander U
    Endocrinology; 2016 Mar; 157(3):1013-20. PubMed ID: 26745543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
    Madak-Erdogan Z; Gong P; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
    Kim JH; Kim YJ
    Endocr J; 2015; 62(6):531-42. PubMed ID: 25877295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function.
    Nordqvist J; Bernardi A; Islander U; Carlsten H
    Immunobiology; 2017 Aug; 222(8-9):918-923. PubMed ID: 28551078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
    Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
    Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).
    Lindsay R
    Osteoporos Int; 2011 Feb; 22(2):447-51. PubMed ID: 21069294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice.
    Noirrit E; Buscato M; Dupuis M; Payrastre B; Fontaine C; Arnal JF; Valera MC
    Endocr Connect; 2019 Jun; 8(6):788-795. PubMed ID: 31085766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH; Mirkin S
    Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.
    Umland EM; Karel L; Santoro N
    Pharmacotherapy; 2016 May; 36(5):548-61. PubMed ID: 27027527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.
    Marlatt KL; Lovre D; Beyl RA; Tate CR; Hayes EK; Burant CF; Ravussin E; Mauvais-Jarvis F
    Eur J Endocrinol; 2020 Oct; 183(4):439-452. PubMed ID: 32698159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in menopausal therapy: the tissue-selective estrogen complex.
    Moore A
    J Am Assoc Nurse Pract; 2013 Mar; 25(3):126-33. PubMed ID: 24218199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Tella SH; Gallagher JC
    Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.